GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Meribank Biotech Co Ltd (ROCO:4724) » Definitions » Price-to-Tangible-Book

Meribank Biotech Co (ROCO:4724) Price-to-Tangible-Book : 4.22 (As of Jun. 05, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Meribank Biotech Co Price-to-Tangible-Book?

As of today (2024-06-05), Meribank Biotech Co's share price is NT$37.30. Meribank Biotech Co's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was NT$8.84. Hence, Meribank Biotech Co's Price to Tangible Book Ratio of today is 4.22.

The historical rank and industry rank for Meribank Biotech Co's Price-to-Tangible-Book or its related term are showing as below:

ROCO:4724' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 4.22   Med: 4.25   Max: 4.32
Current: 4.22

During the past 6 years, Meribank Biotech Co's highest Price to Tangible Book Ratio was 4.32. The lowest was 4.22. And the median was 4.25.

ROCO:4724's Price-to-Tangible-Book is ranked worse than
66.01% of 1221 companies
in the Biotechnology industry
Industry Median: 2.78 vs ROCO:4724: 4.22

A closely related ratio is called PB Ratio. As of today, Meribank Biotech Co's share price is NT$37.30. Meribank Biotech Co's Book Value per Sharefor the quarter that ended in Dec. 2023 was NT$9.32. Hence, Meribank Biotech Co's P/B Ratio of today is 4.00.


Meribank Biotech Co Price-to-Tangible-Book Historical Data

The historical data trend for Meribank Biotech Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meribank Biotech Co Price-to-Tangible-Book Chart

Meribank Biotech Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial - - - - 4.25

Meribank Biotech Co Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 7.65 4.25

Competitive Comparison of Meribank Biotech Co's Price-to-Tangible-Book

For the Biotechnology subindustry, Meribank Biotech Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Meribank Biotech Co's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Meribank Biotech Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Meribank Biotech Co's Price-to-Tangible-Book falls into.



Meribank Biotech Co Price-to-Tangible-Book Calculation

Meribank Biotech Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=37.30/8.836
=4.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Meribank Biotech Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Meribank Biotech Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Meribank Biotech Co (ROCO:4724) Business Description

Traded in Other Exchanges
N/A
Address
Sector 1, Neihu Road, 1st Floor, No.68, Neihu District, Taipei, TWN, 11493
Meribank Biotech Co Ltd is engaged in Research and development and sales of new cell drugs and also Umbilical cord blood, placenta and umbilical cord mesenchymal stem cells processing, testing and cryopreservation.

Meribank Biotech Co (ROCO:4724) Headlines

No Headlines